Please sign in to follow a disease.
Sound wave balloon aims to clear leg arteries without surgery
NCT ID NCT07575568
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new device that combines a balloon with sound waves to treat blocked arteries in the legs, a condition called peripheral artery disease (PAD). The device is designed to crack hard plaque and widen the artery. The study will include 30 people with moderate to severe PAD to see if the procedure is safe and works well.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Serranator Sonic Intravascular Lithotripsy (IVL) System
- What this could lead to
- If successful, this device could offer a new way to open blocked leg arteries without major surgery, potentially improving blood flow and reducing symptoms like leg pain.
- What could go wrong
- This is a very early, small study (30 people) testing safety and effectiveness for the first time. The device may not work as hoped, and risks include artery damage, blood clots, or the need for further procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
\*Inclusion Criteria for Cohort A: ATK arm of the study: Clinical: * Subject is ≥ 18 years of age * Target limb is Rutherford Clinical Category 2, 3 or 4 * Resting ABI of ≤0.90, or TBI ≤0.70 of the target limb Angiographic: * Subject must have a de novo target lesion in a native superficial femoral artery (SFA) or popliteal artery * Reference vessel diameter (RVD) between 4.0 and 8.0mm * Target lesion must have a diameter stenosis of ≥70% * Lesion calcification is at least moderate * Total planned target lesion length must be ≤150mm * Chronic total occlusion lesion length is ≤100mm * Subject has at least one patent tibial vessel on the target limb with runoff to the foot * Exclusion Criteria for Cohort A: ATK arm of the study: Clinical: * Rutherford Clinical Categories 0, 1, 5 and 6 * Subject with known pregnancy or is nursing * Subject has acute or chronic renal disease, defined as serum creatinine of \>2.5 mg/dL or \>220 µmol/L or on dialysis Angiographic: * Target lesions \>150mm by visual estimation * Chronic total occlusions \> 100mm by visual estimation * No or mild calcium present in the target lesion * Inclusion Criteria for Cohort B: BTK arm of the study: Clinical: * Age of subject is ≥18 * Rutherford Clinical Category 2 - 5 (with tissue loss limited to the digits and no evidence of infection) Angiographic: * Single or two target lesion(s) located in a de novo artery distal to the trifurcation vessels * Target vessel reference diameter is between 2.5mm and 4.0 mm * Target lesion with diameter stenosis ≥50% * Target lesion is ≤150mm in length * Subject has at least one patent tibial vessel (\>50%) with run-off to the foot. * Calcification is at least moderate * Exclusion Criteria for Cohort B: BTK arm of the study: Clinical: * Rutherford Clinical Category 0,1 or 6 * Gangrene of the lower extremity * Patient is pregnant or nursing Angiographic: * Target lesion is within only lower extremity vessel with \< 50% stenosis * Target lesion length exceeds 150mm * Patient has chronic total occlusion of target lesion
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Peripheral artery disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a rotating device plus a debris filter keep leg arteries open longer?
- Can a standard blood thinner match a newer combo for preventing heart attacks?
- Could artery disease drain the body's repair cells?
- FitBit coaching may help amputees walk more after surgery
- Can a novel device change treatment? a trial seeks answers
- A simple handheld test could spot hidden artery trouble in diabetic foot wounds